PDB23 ECONOMIC EVALUATION OF DETEMIR-BASED BASAL/BOLUS THERAPY VERSUS NPH-BASED BASAL/BOLUS THERAPY FOR TYPE-1 DIABETES IN GERMANY
Nov 1, 2005, 00:00 AM
10.1016/S1098-3015(10)67642-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)67642-5/fulltext
Section Title :
Section Order :
225
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67642-5&doi=10.1016/S1098-3015(10)67642-5